Centene Corp
Centene Corporation, a Fortune 500 company, is a leading healthcare enterprise that is committed to helping people live healthier lives. The Company takes a local approach with local teams to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured individuals. Centene offers affordable and high-quality products to more than 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace.
Earnings per share grew at a 20.1% CAGR.
Current Price
$53.34
-0.65%GoodMoat Value
$1901.11
3464.1% undervaluedCentene Corp (CNC) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Centene Corp's financial performance and position as a Healthcare company.
Trailing twelve-month (TTM) revenue is $198.10B. Gross profit (TTM) is $14.22B. EBITDA is $-4.43B. Earnings per share (EPS) is $-13.53. The P/E ratio is -4.07. Market capitalization is $26.23B.
Free cash flow (FCF) is $4.32B. FCF growth rate is 33.80%. EPS growth CAGR is 20.13%. Weighted average cost of capital (WACC) is 10.00%.
Historical revenue data covers 7 years from FY19 to FY25. Net income history spans 7 years. Free cash flow and capital expenditure data spans 7 years. GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.
Use Centene Corp's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.
